Cargando…
Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016–2021
Objectives: Elderly lung cancer patients often have chronic diseases other than lung cancer. Therefore, this kind of population is often accompanied by polypharmacy. This situation and the resulting potentially inappropriate medication (PIM) use are an increasing global concern. In this context, the...
Autores principales: | Tian, Fangyuan, Chen, Zhaoyan, Tang, Rui, Feng, Qiyi, Wu, Fengbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581179/ https://www.ncbi.nlm.nih.gov/pubmed/36278193 http://dx.doi.org/10.3389/fphar.2022.992394 |
Ejemplares similares
-
The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
por: Tian, Fangyuan, et al.
Publicado: (2021) -
Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis
por: Tian, Fangyuan, et al.
Publicado: (2022) -
Prescription of Potentially Inappropriate Medication Use in Older Cancer Outpatients With Multimorbidity: Concordance Among the Chinese, AGS/Beers, and STOPP Criteria
por: Tian, Fangyuan, et al.
Publicado: (2022) -
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023) -
Prevalence of polypharmacy and potentially inappropriate medication use in older lung cancer patients: A systematic review and meta-analysis
por: Tian, Fangyuan, et al.
Publicado: (2022)